Tema ETFs
ORIC icon

Tema ETFs’s Oric Pharmaceuticals ORIC Stock Holding History

Tema ETFs’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.52M Buy
113,079
+55,102
+95% +$686K 0.06% 229
2026
Q2 		$628K Buy
57,977
+750
+1% +$6.8K 0.02% 370
2026
Q1 		$725K Buy
57,227
+29,373
+105% +$333K 0.05% 291
2025
Q4 		$228K Buy
+27,854
New +$321K 0.02% 475
2025
Q2 		– Sell
-40,934
Closed -$228K – 171
2025
Q1 		$228K Sell
40,934
-4,542
-10% -$39.7K 0.07% 138
2024
Q4 		$367K Buy
+45,476
New +$417K 0.15% 120

Other funds holding ORIC

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Tema ETFs's ORIC Position: Q3 2026 in Review

Tema ETFs increased its Oric Pharmaceuticals (ORIC) stake by 95% in Q3 2026, buying an estimated $686K and bringing the position to 113,079 shares worth $1.52M. The position accounts for 0.06% of the portfolio, ranked #229.

Tema ETFs first reported a position in ORIC in Q4 2024 and has held it in 6 quarters since. 13 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Tema ETFs held 113,079 shares of Oric Pharmaceuticals worth $1.52M as of Q3 2026.
  • Tema ETFs bought 55,102 Oric Pharmaceuticals shares in Q3 2026, an estimated $686K.
  • Oric Pharmaceuticals made up 0.06% of Tema ETFs's portfolio in Q3 2026, its #229 holding.
  • Tema ETFs first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 13 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.